STOCK TITAN
  1. Home
  2. News
  3. CRON

Cronos Group Inc. Common Share - CRON STOCK NEWS

Welcome to our dedicated page for Cronos Group Common Share news (Ticker: CRON), a resource for investors and traders seeking the latest updates and insights on Cronos Group Common Share stock.

Cronos Group Inc. (CRON) is a globally diversified and vertically integrated cannabis company with a significant presence across four continents. Headquartered in Toronto, Canada, Cronos operates two wholly-owned Canadian licensed producers, Peace Naturals Project Inc. based in Ontario, and Original BC Ltd. located in British Columbia's Okanagan Valley. These operations are regulated under Health Canada's Access to Cannabis for Medical Purposes Regulations.

Internationally, Cronos has established production and distribution platforms in Israel and Australia, and through an exclusive distribution agreement, has access to over 12,000 pharmacies in Germany. The company focuses on building an iconic brand portfolio and developing disruptive intellectual property, aiming to be a leader in the global cannabis market.

Cronos's medicinal brand, Peace Naturals, and recreational brands, Cove and Spinach, cater to a wide range of consumers. The company exports medical cannabis primarily to Israel, and in the U.S., it holds an option to acquire 10.5% of U.S. multistate operator PharmaCann upon the easing of federal restrictions.

Recently, Cronos has expanded its footprint in Australia, partnering with Vitura to supply high-quality cannabis products. This milestone is significant as the Australian medical cannabis market has grown impressively, with approvals for new patients increasing each year. Additionally, Cronos's Spinach brand has become a top seller in Canada, particularly in the flower and edibles categories.

With a strong emphasis on R&D, Cronos invests in tissue culture and cannabis genetics breeding programs to ensure premium quality. This commitment has enabled the company to produce high-quality products that meet the growing demand in international markets, including the UK and Germany.

The company is also known for its commitment to responsible cannabis research, technology, and product development. With a focus on advancing consumer experiences, Cronos continues to innovate and expand its product offerings globally.

News

Cronos Group Inc. to Hold 2023 Fourth Quarter and Full-Year Earnings Conference Call on February 29, 2024

Rhea-AI Summary
Cronos Group Inc. will hold its 2023 fourth quarter and full-year earnings conference call on February 29, 2024. The senior management team will discuss financial results and take questions from the investment community. Participants can register online for the webcast.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.27%
Tags
earnings
-
News

Cronos’ Spinach® Brand Ends 2023 as the Number One Flower Brand in Canada1

Rhea-AI Summary
Cronos Group Inc. announced that its brand, Spinach®, closed 2023 as the number one ranked flower brand in Canada with a 6.9% market share in the fourth quarter. The Spinach® flower products have resonated strongly with consumers, leading to a significant increase in its ranking from the fourth best-selling flower brand in 2022, to become the best-selling flower brand in Canada in 2023. The Spinach® product portfolio is ranked as the second best-selling cannabis brand in Canada across all categories as of December 2023. In 2023, Spinach® products held a number 1 position in the flower and edibles categories, and a top-10 ranking in the pre-rolls and vape categories. The Spinach® team successfully launched six new flower SKUs and seven new pre-roll SKUs in 2023. Cronos’ sophisticated breeding program and unique portfolio of genetics has helped the Company win in the highly competitive Canadian market, as well as expand Cronos’ international footprint with distribution to the growing markets in Germany and Australia.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1%
Tags
none
-
News

Cronos Enters Australian Cannabis Market

Rhea-AI Summary
Cronos Group Inc. (CRON) expands distribution into the Australian market with its first shipment of cannabis flower to Vitura Health Limited (VIT). Cronos owns approximately 10% of the common shares of Vitura and will supply cannabis for Vitura. The Australian medical cannabis market has seen impressive growth in patient approvals and sales, and Cronos aims to help establish Vitura as a leading cannabis brand in Australia.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.02%
Tags
none
News

Premium Cannabis Brand Lord Jones® Launches Live Resin Vapes

Rhea-AI Summary
Cronos Group Inc. (CRON) launches Lord Jones® Live Resin Vapes, featuring curated strains, pure live resin, and high-quality hardware. The products offer a multi-dimensional, true-to-plant experience with THC levels exceeding 70%. The vapes are available in two hardware options and versatile sizing options, catering to both enthusiasts and new consumers. The products will be available in select Canadian provinces in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.5%
Tags
none
-
News

Cronos Group Inc. enters into agreement for the sale-leaseback of its Stayner, Ontario facility

Rhea-AI Summary
Cronos Group Inc. (CRON) announced the sale and leaseback of its Peace Naturals Campus to Future Farmco Canada Inc. for C$23 million cash, aiming to reduce costs and improve the gross margin profile of the business. The transaction is subject to certain conditions and is expected to close within 30 calendar days after all conditions are satisfied or waived.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.88%
Tags
none
-
News

Cronos Group Reports 2023 Third Quarter Results

Rhea-AI Summary
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) announces its 2023 Q3 business results, with net revenue increasing by 22% year-over-year to $24.8 million. Spinach® achieved top-10 retail sales in Canada in Q3 2023 across various categories. The company also launched the Peace Naturals® brand in Germany and the award-winning Lord Jones® brand in Canada.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.82%
Tags
earnings
News

Lord Jones®, an Award-Winning Premium Cannabis Brand, Launches with Ice Water Hash Fusions Pre-Rolls in Canada

Rhea-AI Summary
Cronos Group Inc. has launched its Lord Jones® cannabis brand in the Canadian adult-use market. The brand will focus on THC-focused product innovations and deliver premium quality cannabis products. The first product to launch is the Lord Jones® Hash Fusions pre-rolls, which are crafted with an optimized ratio of high-potency flower and ice water hash. The pre-rolls offer a smooth smoke and bold cannabis flavors. Lord Jones® Hash Fusions will be available in select provinces this month and expanding to other provinces in early 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.64%
Tags
none
-
News

Cronos Unveils its New THCV Products: Spinach FEELZ™ Full Tilt

Rhea-AI Summary
Cronos Group Inc. has announced the launch of two new THCV-infused products, including a vape and gummy under the Spinach FEELZ™ brand. The Full Tilt THCV lineup aims to provide adult consumers with a unique cannabis experience. The vape contains 700mg of THC and 100mg of THCV per 1g cartridge, while the gummies offer 10mg of THC and 20mg of THCV per pack. The THCV vape is currently available in Alberta, British Columbia, and Ontario, and the THCV edibles are available in Ontario and British Columbia, with availability in Alberta expected by November 30. THCV-infused pre-rolls are planned for launch in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.91%
Tags
none
-
News

Cronos Group Inc. to Hold 2023 Third Quarter Earnings Conference Call on November 8, 2023

Rhea-AI Summary
Cronos Group Inc. will hold its 2023 Q3 earnings conference call on November 8. Senior management will discuss financial results and take questions from the investment community.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.81%
Tags
earnings
News

Cronos brand Spinach® Wins Best Pre-Roll at Grow Up Awards

Rhea-AI Summary
Cronos Group's Spinach® brand wins 'Best Pre-Roll' at the Grow Up Awards for its Spinach® Fully Charged Atomic GMO infused pre-rolls.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the current stock price of Cronos Group Common Share (CRON)?

The current stock price of Cronos Group Common Share (CRON) is $2.05 as of November 21, 2024.

What is the market cap of Cronos Group Common Share (CRON)?

The market cap of Cronos Group Common Share (CRON) is approximately 799.0M.

What does Cronos Group Inc. do?

Cronos is a global cannabis company that cultivates and sells medicinal and recreational cannabis through its brands Peace Naturals, Cove, and Spinach.

Where is Cronos Group headquartered?

Cronos Group is headquartered in Toronto, Canada.

Which brands does Cronos Group own?

Cronos Group owns Peace Naturals, Cove, and Spinach.

What are Cronos Group's international operations?

Cronos Group operates in Israel, Australia, and Germany, and has access to over 12,000 pharmacies in Germany through an exclusive distribution agreement.

What recent achievement has Cronos made in Australia?

Cronos has partnered with Vitura to supply high-quality cannabis products to the growing Australian medical cannabis market.

What is the significance of the Spinach brand for Cronos?

The Spinach brand has become a top seller in Canada, particularly in the flower and edibles categories, contributing significantly to Cronos's market presence and growth.

Does Cronos export medical cannabis to other countries?

Yes, Cronos primarily exports medical cannabis to Israel and is expanding its international markets including the UK and Germany.

What research and development efforts is Cronos involved in?

Cronos invests in R&D, including tissue culture and cannabis genetics breeding programs, to ensure premium quality products and innovation in cannabis research and technology.

What is Cronos's goal in the cannabis market?

Cronos aims to build an international iconic brand portfolio and develop disruptive intellectual property to lead the global cannabis market.

What option does Cronos hold in the United States?

Cronos holds an option to acquire 10.5% of U.S. multistate operator PharmaCann upon the easing of federal prohibition.

Stock CRON logo
Cronos Group Inc. Common Share

Nasdaq:CRON

CRON Rankings

#2733 Ranked by Market Cap
N/A Ranked by Dividends

CRON Stock Data

799.00M
200.33M
46.4%
15.62%
1.02%
Drug Manufacturers - Specialty & Generic
Medicinal Chemicals & Botanical Products
Link
United States of America
STAYNER